ConductScience.org, home

Paper17524101

Transfusion premedications: a growing practice not based on evidence.

Tobian AA and 2 others. Transfusion, 2007. Cited by 49 papers, by iCite.

Cite this record

ConductScience Library. Transfusion premedications: a growing practice not based on evidence. Papers, record 17524101. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17524101

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Transfusion premedications: a growing practice not based on evidence.
PubMed
Journal
Transfusion
PubMed
Year
2007
PubMed
Publication types
Comparative Study, Historical Article, Journal Article, Review
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
1.68
iCite
Revised in PubMed
2020-12-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tobian AAAaron A R
2King KEKaren E
3Ness PMPaul M

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Erythrocyte TransfusionMajor topic
HypersensitivityMajor topic
Leukocyte Reduction ProceduresMajor topic
Platelet TransfusionMajor topic
PremedicationMajor topic
Blood Group Incompatibility
Evidence-Based Medicine
History, 20th Century
Humans
Incidence
Institutional Practice
Respiratory Distress Syndrome
Sepsis

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
42936835Transfusion Management in Pregnancies Complicated by Hemoglobinopathies: Evidence, Guidelines, and Clinical Challenges.Matern Fetal Med2026https://conductscience.org/library/papers/42936835PubMed
40681467Transfusion strategies in thalassemia and sickle cell disease SITE-SIMTI-SIdEM Good Practice.Blood Transfus2025https://conductscience.org/library/papers/40681467PubMed
35720859Improving Blood Product Transfusion Premedication Plan Documentation: A Single-institution Quality Improvement Effort.Pediatr Qual Saf2022https://conductscience.org/library/papers/35720859PubMed
34453453The transfusion management of beta thalassemia in the United States.Transfusion2021https://conductscience.org/library/papers/34453453PubMed
31914091Autoimmune hemolytic anemia in hospitalized patients: 450 patients and their red blood cell transfusions.Medicine (Baltimore)2020https://conductscience.org/library/papers/31914091PubMed
28090496Steps taken to alleviate under-reporting of transfusion reactions at a public sector hospital in Pakistan.Blood Res2016https://conductscience.org/library/papers/28090496PubMed
27079627Platelet transfusion therapy in sub-Saharan Africa: bacterial contamination, recipient characteristics, and acute transfusion reactions.Transfusion2016https://conductscience.org/library/papers/27079627PubMed
25209730Transfusion and component characteristics are not associated with allergic transfusion reactions to apheresis platelets.Transfusion2015https://conductscience.org/library/papers/25209730PubMed
25065959Transfusion-related adverse events in the Platelet Dose study.Transfusion2015https://conductscience.org/library/papers/25065959PubMed
24517134Desensitization in allergic transfusion reactions: evidence from the Trial to Reduce Alloimmunization to Platelets.Transfusion2014https://conductscience.org/library/papers/24517134PubMed
24251374The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME).Transfusion2014https://conductscience.org/library/papers/24251374PubMed
23363552The cost-effectiveness of platelet additive solution to prevent allergic transfusion reactions.Transfusion2013https://conductscience.org/library/papers/23363552PubMed
22998777Scratching the surface of allergic transfusion reactions.Transfusion2013https://conductscience.org/library/papers/22998777PubMed
22233358The impact of apheresis platelet manipulation on corrected count increment.Transfusion2012https://conductscience.org/library/papers/22233358PubMed
21883267Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions.Transfusion2012https://conductscience.org/library/papers/21883267PubMed
21569041Atopic predisposition of recipients in allergic transfusion reactions to apheresis platelets.Transfusion2011https://conductscience.org/library/papers/21569041PubMed
21214586Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes.Transfusion2011https://conductscience.org/library/papers/21214586PubMed
20556779Pharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactions.Cochrane Database Syst Rev2010https://conductscience.org/library/papers/20556779PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17524101

GET https://conductscience.org/api/papers/v1/17524101/authors